Watts Ryan J. bought DNLI
July 9, 2025 · Form 4 insider transaction
Watts Ryan J. bought 40,000 shares of Denali Therapeutics Inc. at $5.28 per share, a transaction worth $211.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$5.28
Total value
$211.2K
InsiderWatts Ryan J.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 9, 2025
Filing dateJuly 11, 2025
Shares owned after748,353
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 177,940 Unvested RSUs.